Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease

NCT07834372 is registered in ClinicalTrials.gov with HeartFlow, Inc. as lead sponsor.

NCT NCT07834372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07834372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease
Lead sponsor
HeartFlow, Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
April 30, 2029
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cad - coronary artery disease